View in EDS HTML Full Text PDF Full Text

MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.

Saved in:
Bibliographic Details
Title: MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.
Authors: Nakashoji A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Bhattacharya A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ozawa H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Haratake N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Shigeta K; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Fushimi A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Yamashita N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Matsui A; Department of Breast Surgery, National Hospital Organization Tokyo Medical Center, Tokyo, Japan., Kure S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Kameyama T; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Takeuchi M; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Fukuda K; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Yokoe T; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Nagayama A; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Hayahsida T; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Kitagawa Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Liu R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Giordano A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Jeselsohn R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Shapiro GI; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Kufe D; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Donald_Kufe@dfci.harvard.edu.
Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Apr 26; Vol. 11 (1), pp. 39. Date of Electronic Publication: 2025 Apr 26.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40287441
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nakashoji+A%22">Nakashoji A</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bhattacharya+A%22">Bhattacharya A</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ozawa+H%22">Ozawa H</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Haratake+N%22">Haratake N</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shigeta+K%22">Shigeta K</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fushimi+A%22">Fushimi A</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Yamashita+N%22">Yamashita N</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Matsui+A%22">Matsui A</searchLink>; Department of Breast Surgery, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kure+S%22">Kure S</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kameyama+T%22">Kameyama T</searchLink>; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takeuchi+M%22">Takeuchi M</searchLink>; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuda+K%22">Fukuda K</searchLink>; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yokoe+T%22">Yokoe T</searchLink>; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nagayama+A%22">Nagayama A</searchLink>; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hayahsida+T%22">Hayahsida T</searchLink>; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kitagawa+Y%22">Kitagawa Y</searchLink>; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Liu+R%22">Liu R</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Giordano+A%22">Giordano A</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Jeselsohn+R%22">Jeselsohn R</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shapiro+GI%22">Shapiro GI</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kufe+D%22">Kufe D</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Donald_Kufe@dfci.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2025 Apr 26; Vol. 11 (1), pp. 39. <i>Date of Electronic Publication: </i>2025 Apr 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40287441
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-025-00751-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 39
    Titles:
      – TitleFull: MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nakashoji A
      – PersonEntity:
          Name:
            NameFull: Bhattacharya A
      – PersonEntity:
          Name:
            NameFull: Ozawa H
      – PersonEntity:
          Name:
            NameFull: Haratake N
      – PersonEntity:
          Name:
            NameFull: Shigeta K
      – PersonEntity:
          Name:
            NameFull: Fushimi A
      – PersonEntity:
          Name:
            NameFull: Yamashita N
      – PersonEntity:
          Name:
            NameFull: Matsui A
      – PersonEntity:
          Name:
            NameFull: Kure S
      – PersonEntity:
          Name:
            NameFull: Kameyama T
      – PersonEntity:
          Name:
            NameFull: Takeuchi M
      – PersonEntity:
          Name:
            NameFull: Fukuda K
      – PersonEntity:
          Name:
            NameFull: Yokoe T
      – PersonEntity:
          Name:
            NameFull: Nagayama A
      – PersonEntity:
          Name:
            NameFull: Hayahsida T
      – PersonEntity:
          Name:
            NameFull: Kitagawa Y
      – PersonEntity:
          Name:
            NameFull: Liu R
      – PersonEntity:
          Name:
            NameFull: Giordano A
      – PersonEntity:
          Name:
            NameFull: Jeselsohn R
      – PersonEntity:
          Name:
            NameFull: Shapiro GI
      – PersonEntity:
          Name:
            NameFull: Kufe D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 04
              Text: 2025 Apr 26
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1